Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Hinge Health (HNGE) EPS (Weighted Average and Diluted) (2024 - 2025)

Hinge Health (HNGE) has disclosed EPS (Weighted Average and Diluted) for 2 consecutive years, with $2.11 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 4.98% to $2.11 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$9.0 through Dec 2025, down 955.57% year-over-year, with the annual reading at -$7.77 for FY2025, 782.95% down from the prior year.
  • EPS (Weighted Average and Diluted) hit $2.11 in Q4 2025 for Hinge Health, up from -$0.02 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $2.11 in Q4 2025 to a low of -$13.1 in Q2 2025.